Contents

Issue 100 • November 2020

In association with

Could vaccine hesitancy impact the fight against Covid-19?

We examine the potential impact of the growing anti-vax movement on Covid-19 vaccination efforts

IN DEPTH

Diversity in Covid-19 clinical trials

Comment

Atomwise: AI in drug discovery

Briefing

Industry news

Pharma industry briefing

Covid-19 briefing

Comment

Trump and Biden: Covid-19 response

Covid-19 disruption to clinical trials

Promising Covid-19 vaccine candidates

In Depth

Vaccine research without animal testing

Drug development for gout treatment

Treating chronic pain without painkillers

Disrupting the breast cancer ecosystem

Quantum computing in life sciences

In Data

Inside the deal

Deals analysis

Market data

02/24/2024 00:07:56
  • Home | Covid-19 and the anti-vax movement
  • In this issue
  • Contents
  • Accurate Biometrics Company Insight
  • Accurate Biometrics
  • Contract Pharmaceuticals Limited Canada
  • Mettler Toledo Company Insight
  • Mettler Toledo
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Wipotec
  • Purolite
  • VEGA Australia
  • Gerteis Company Insight
  • Gerteis
  • Comment
  • US election: Trump and Biden's priorities in the Covid-19 response
  • Covid-19 disruption to trials declines, but recruitment is slow
  • Covid-19 vaccine developments across the globe
  • Eli Lilly and Regeneron’s EUA bids trigger concerns over available Covid-19 data
  • AstraZeneca’s quick Covid-19 vaccine trial restart splits opinion
  • Q&A: Atomwise’s journey from discoverer to developer
  • Pfeiffer Vacuum
  • Koehler eClinical
  • Phoenix Company Insight
  • Phoenix
  • In Depth
  • How to combat vaccine hesitancy in the age of Covid-19
  • How Covid-19 has put clinical research’s diversity problem in the spotlight
  • No need for animal testing: improving vaccine research with Genoskin
  • Gout: drug development for an age-old disease
  • Treating chronic primary pain in the UK
  • Breast cancer breakthrough: could a new therapy silence stubborn TNBC?
  • Is quantum computing pharma's next big disruptor?
  • Mimotopes
  • Optel
  • Solvias Company Insight
  • Solvias
  • HOF Sonderanlagenbau Company Insight
  • HOF Sonderanlagenbau
  • In Data
  • Inside the deal
  • Deals analysis
  • The pharma industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • IWA Consulting Company Insight
  • IWA consulting
  • Nipro pharmapackaging
  • Swiftpak
  • Events
  • Next issue
10/23/2020 00:00:00